Morris Innovative, Inc.

According to the American Heart Association, 1.3 million percutaneous coronary interventions such as angioplasty are carried out in the US each year, mainly via the femoral artery. Although such proce

Although the vascular access repair products market continues to be dominated by two multinationals, St. Jude Medical Inc. and Abbott Vascular / Abbott Laboratories Inc. , their share will be

by Mary Thompson The rapid proliferation of catheter-based interventional devices and procedures over the past two decades has revolutionized the diagnosis and treatment of coronary and peripheral vas

Despite the best intentions and brightest innovation, start-ups haven’t been able to tap into the huge potential presented by the vascular closure market. But the opportunity simply is too big for the